{
  "resourceType" : "CodeSystem",
  "id" : "med-clinical-category-cs",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem med-clinical-category-cs</b></p><a name=\"med-clinical-category-cs\"> </a><a name=\"hcmed-clinical-category-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">CHEMOTHERAPY<a name=\"med-clinical-category-cs-CHEMOTHERAPY\"> </a></td><td>Chemotherapy</td><td>Cytotoxic agent used to kill or inhibit cancer cells.</td></tr><tr><td style=\"white-space:nowrap\">IMMUNOTHERAPY<a name=\"med-clinical-category-cs-IMMUNOTHERAPY\"> </a></td><td>Immunotherapy</td><td>Agent that stimulates the immune system against cancer.</td></tr><tr><td style=\"white-space:nowrap\">TARGETED-THERAPY<a name=\"med-clinical-category-cs-TARGETED-THERAPY\"> </a></td><td>Targeted Therapy</td><td>Agent targeting specific molecular markers on cancer cells.</td></tr><tr><td style=\"white-space:nowrap\">HORMONAL-THERAPY<a name=\"med-clinical-category-cs-HORMONAL-THERAPY\"> </a></td><td>Hormonal Therapy</td><td>Agent that blocks or modifies hormone-driven tumour growth.</td></tr><tr><td style=\"white-space:nowrap\">SUPPORTIVE-CARE<a name=\"med-clinical-category-cs-SUPPORTIVE-CARE\"> </a></td><td>Supportive Care</td><td>Medication to manage side effects or improve tolerability.</td></tr><tr><td style=\"white-space:nowrap\">ANTI-EMETIC<a name=\"med-clinical-category-cs-ANTI-EMETIC\"> </a></td><td>Anti-emetic</td><td>Agent to prevent or treat nausea and vomiting.</td></tr><tr><td style=\"white-space:nowrap\">GROWTH-FACTOR<a name=\"med-clinical-category-cs-GROWTH-FACTOR\"> </a></td><td>Growth Factor</td><td>Colony-stimulating factor to support blood cell recovery.</td></tr><tr><td style=\"white-space:nowrap\">CORTICOSTEROID<a name=\"med-clinical-category-cs-CORTICOSTEROID\"> </a></td><td>Corticosteroid</td><td>Steroid given as part of or to support the oncology regimen.</td></tr><tr><td style=\"white-space:nowrap\">BISPHOSPHONATE<a name=\"med-clinical-category-cs-BISPHOSPHONATE\"> </a></td><td>Bisphosphonate</td><td>Agent for prevention or treatment of bone metastasis.</td></tr><tr><td style=\"white-space:nowrap\">ANALGESIC<a name=\"med-clinical-category-cs-ANALGESIC\"> </a></td><td>Analgesic</td><td>Pain management medication in the cancer care context.</td></tr></table></div>"
  },
  "url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/med-clinical-category-cs",
  "version" : "0.1.0",
  "name" : "MedClinicalCategoryCS",
  "title" : "Kenya Medication Clinical Category Code System",
  "status" : "active",
  "experimental" : false,
  "date" : "2026-06-04T14:49:30+00:00",
  "publisher" : "Digital Health Agency (DHA), Kenya",
  "contact" : [{
    "name" : "Digital Health Agency (DHA), Kenya",
    "telecom" : [{
      "system" : "url",
      "value" : "https://dha.go.ke"
    },
    {
      "system" : "email",
      "value" : "info@dha.go.ke"
    }]
  },
  {
    "name" : "Digital Health Agency Kenya – FHIR Team",
    "telecom" : [{
      "system" : "email",
      "value" : "info@dha.go.ke",
      "use" : "work"
    },
    {
      "system" : "url",
      "value" : "https://dha.go.ke",
      "use" : "work"
    }]
  }],
  "description" : "Codes classifying the clinical role of a medication within an oncology regimen.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "KE",
      "display" : "Kenya"
    }]
  }],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 10,
  "concept" : [{
    "code" : "CHEMOTHERAPY",
    "display" : "Chemotherapy",
    "definition" : "Cytotoxic agent used to kill or inhibit cancer cells."
  },
  {
    "code" : "IMMUNOTHERAPY",
    "display" : "Immunotherapy",
    "definition" : "Agent that stimulates the immune system against cancer."
  },
  {
    "code" : "TARGETED-THERAPY",
    "display" : "Targeted Therapy",
    "definition" : "Agent targeting specific molecular markers on cancer cells."
  },
  {
    "code" : "HORMONAL-THERAPY",
    "display" : "Hormonal Therapy",
    "definition" : "Agent that blocks or modifies hormone-driven tumour growth."
  },
  {
    "code" : "SUPPORTIVE-CARE",
    "display" : "Supportive Care",
    "definition" : "Medication to manage side effects or improve tolerability."
  },
  {
    "code" : "ANTI-EMETIC",
    "display" : "Anti-emetic",
    "definition" : "Agent to prevent or treat nausea and vomiting."
  },
  {
    "code" : "GROWTH-FACTOR",
    "display" : "Growth Factor",
    "definition" : "Colony-stimulating factor to support blood cell recovery."
  },
  {
    "code" : "CORTICOSTEROID",
    "display" : "Corticosteroid",
    "definition" : "Steroid given as part of or to support the oncology regimen."
  },
  {
    "code" : "BISPHOSPHONATE",
    "display" : "Bisphosphonate",
    "definition" : "Agent for prevention or treatment of bone metastasis."
  },
  {
    "code" : "ANALGESIC",
    "display" : "Analgesic",
    "definition" : "Pain management medication in the cancer care context."
  }]
}